1 December 2023 Professor Tim Hubbard announced as the next ELIXIR Director Professor Tim Hubbard will be responsible for leading ELIXIR’s technical and scientific programmes Health
30 November 2023 High altitude training shows promise for patients ahead of surgery Simulated high altitude could help older patients at risk of health complications related to… Health
30 November 2023 Specialised motor neuron region affected in amyotrophic lateral sclerosis New study identifies the axon initial segment as the region driving abnormal regulation of neuronal… Health
1 November 2023 Breakthrough discovery sheds light on heart and muscle health An international team, led by the Max Planck Institute in Dortmund in collaboration with King's… Health
30 October 2023 Global Atopic Dermatitis Atlas (GADA) to become a leading open resource within atopic dermatitis Funding from the LEO Foundation marks a significant milestone for GADA Health
26 October 2023 New RNA-regulating proteins found to be key in severe asthma A new publication has shown for the first time how two proteins that bind to RNA contribute to the… Health
23 October 2023 King's set to launch new master's course on Applied Bioinformatics The Faculty of Life Sciences & Medicine will be launching the new postgraduate MSc course for 2024… Technology & Science University
17 October 2023 New multidisciplinary natural sciences degree launched at King's Starting in September 2024, the undergraduate degree aims to empower students to solve major… Health Technology & Science University
29 September 2023 Professor Tim Hubbard appointed to prestigious WHO Technical Advisory Group Professor Tim Hubbard has become one of fifteen appointees to the new Technical Advisory Group (TAG)… Health Technology & Science
19 September 2023 Clinical trial recommends methotrexate for children with severe atopic dermatitis Findings from a clinical trial has recommended methotrexate for children with severe atopic… Health